Your address will show here +12 34 56 78
Uncategorized
The 2025 IMCAS World Congress, one of the most anticipated events in the dermatology and aging science community, is set to take place in Paris from January 30 to February 1, 2025. This global gathering will showcase the latest breakthroughs and innovations in the field, featuring over 350 exhibitors presenting cutting-edge products and technologies.

In an exciting development, Avisé Labs is thrilled to announce that their CEO will be presenting alongside Stanford Professor Anne L. Chang at this year’s IMCAS World Congress. The presentation will take place as part of the Skin & Digital Summit, a key focus area of the congress.

The talk, titled „What You See Is Not What You Get: Why Image Data Alone Falls Short & Key Factors for Machine Learning Success,“ promises to be a thought-provoking exploration of the complexities involved in leveraging artificial intelligence in dermatology. Professor Chang, known for her expertise in dermatology and her work as the Founding Director of the Advanced Basal Cell Carcinoma Clinic and co-founding director of the Skin Longevity Program at Stanford, brings a wealth of experience in clinical trials and translational research to the discussion. Her background in investigating mechanisms underlying skin aging, rejuvenation, and longevity will undoubtedly provide valuable insights.

This collaboration between industry and academia exemplifies the innovative spirit of IMCAS World Congress, fostering discussions that bridge cutting-edge technology with clinical expertise. The congress aims to showcase not only the highest quality and factually valid science but also the latest developments and areas of expansion in dermatology and aging science. With sessions covering a wide range of topics from clinical dermatology and lasers to practice management and ethics, IMCAS 2025 promises to offer valuable insights for all attendees.

For those interested in attending this groundbreaking presentation and exploring the intersection of AI and dermatology, more information can be found on the official IMCAS website: https://www.imcas.com/en/attend/imcas-world-congress-2025/program/session/55783
0

News

We are proud to be among the best German employers of 2024 in the category of companies with up to 100 employees. And by the way, we are the only ones in this category in the medical technology sector 🙂

Handelsblatt, together with the market research institute SWI Human Resources (SWI HR), examined how companies are positioned in terms of diversity, equal opportunities, and freedom from discrimination. Criteria for fair career advancement were investigated, with nearly 2000 companies surveyed about strategies and measures and evaluated with points.

According to this ranking, avisé labs is among the best employers of 2024!We are infinitely grateful to be able to work with such a great team and such wonderful partners and customers.

You can read the article in today’s print version of Handelsblatt

or here: https://media.handelsblatt.com/handelsblatt/downloads/2024/Handelsblatt_Beste_Arbeitgeber_2024.pdf

The online article is here:

https://www.handelsblatt.com/karriere/karriere-diese-unternehmen-sind-vorreiter-in-sachen-vielfalt/100076047.html

0

News
We are excited to share that avisé labs has published a new research paper in the Journal of Cosmetic Dermatology, in collaboration with our esteemed international partners.
The paper „AI in Aesthetic/Cosmetic Dermatology: Current and Future“ discusses current trends, challenges and future directions of applying AI in dermatology. 

You can access the paper here: 
J of Cosmetic Dermatology – 2024 – Thunga – AI in Aesthetic Cosmetic Dermatology Current and Future
0

News, Talk

We are thrilled to announce our participation at KOREADERMA 2024 this November in Seoul, Korea! 🇰🇷

Our CEO will be speaking in the highly anticipated AI Session, discussing the intersection between AI and medicine, especially in dermatology. This is a unique opportunity to explore how artificial intelligence is transforming medical care, from enhancing diagnostics to driving innovative treatments.

In addition to sharing insights, we are also excited to explore new business opportunities in Korea and collaborate with local partners to push the boundaries of healthcare innovation.

Join us and be part of the conversation shaping the future of AI and medicine!

For more information please click here: https://www.koreaderma.org/
 

0

Uncategorized

The German AI Startup Landscape is Germany’s most comprehensive and respected analysis of the AI startup scene, highlighting the incredible work being done by the AI startups across various enterprise functions, technologies, and industries.

This year, Deutsche Telekom, NVIDIA, Intel Corporation, UnternehmerTUM, Cherry Ventures, Earlybird Venture Capital, UVC Partners, Yttrium, HTGF | High-Tech Gründerfonds, eCapital Corp., Burda Principal Investments, HV Capital, D11Z. Ventures GmbH & Co. KG., MIG Capital and the AI.FUND participated in the selection process of the most promising AI startups in Germany.

You can find further information about the selection process as well as a detailed analysis of the German AI Startup Landscape here: https://lnkd.in/eXmq4KuP

Also, the  WirtschaftsWoche  covered the AI Startup Landscape 2024. Please find the articles in the following:
  1. https://www.wiwo.de/technologie/digitale-welt/kuenstliche-intelligenz-das-sind-deutschlands-ki-hochburgen-/29920056.html 
  2. https://www.wiwo.de/technologie/digitale-welt/kuenstliche-intelligenz-die-27-vielversprechendsten-ki-start-ups-in-deutschland/29919936.html 
  3. https://www.wiwo.de/technologie/digitale-welt/start-up-landschaft-bei-ki-erlebt-deutschland-eine-neue-gruenderzeit/29917562.html
Again, also this year, we are thrilled that the appliedAI Institute and their partners selected avisé labs again in 2024 as one of the most promising AI Startups in Germany!  

We are proud of being part of the AI Startup Landscape and are looking forward to great collaborations and future projects within the AI startup community!
0

News
In a recent conversation, Jane Yoo, MD, a leading dermatologist in New York City, and our CEO Marius Khan discussed the rising influence of artificial intelligence (AI) in dermatology and medicine.

This interview is printed in the February-March 2024 issue of Modern Aesthetics, accessible at

https://modernaesthetics.com/articles/2024-jan-feb/the-art-of-software-design-in-dermatology-and-aesthetic-medicine/pdf 

You can download the PDF also HERE

0

News

This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.   

Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute

avisé labs is also attending this event in person in 2024 to establish new partnerships for innovative medical applications fostered by intelligent software approaches. We are looking forward to connecting with you at Stanford!

Link to the conference:

https://med.stanford.edu/cvi/events/2024-drug-discovery-conference.html

0

News

This year, NVIDIA, Intel and twelve renowned venture capital firms (Cherry Ventures, Earlybird Capital, UVC Partners, Yttrium, Lakestar, High-Tech Founder Funds, eCAPITAL, La Famiglia, Asgard, Burda Principal Investments, HV Capital, and Born2Grow), participated in the selection process of the most promising AI Startups in Germany. You can find further information about the selection process as well as the detailed analysis of the German AI Startup Landscape here.


The AI Startup Landscape is Germany’s most comprehensive and respected analysis of the AI startup scene, highlighting the incredible work being done by AI Startups across various enterprise functions, intelligence, technology types, and industries. This year, the AI Startup Landscape was covered in several articles in the WirtschaftsWoche (Link to Article 1 | Link to Article 2 | Link to Article 3).


The appliedAI Institute, along with their esteemed partners from academia, government, and industry, has been dedicated to creating an ecosystem where AI startups can thrive and contribute to shaping the future of AI for the betterment of society. One of their key objectives is to facilitate partnerships and collaboration opportunities between startups and corporations to enhance knowledge sharing and foster AI adoption.


To support this endeavor, the appliedAI Institute has developed a centralized database of high-quality and externally validated AI startups. This platform aims to provide easy access for corporations, SMEs, and governmental institutions to connect with trusted AI partners. 


We are thrilled that the appliedAI Institute and their partners selected avisé labs as one of the most promising AI Startups in Germany!  


We are proud of being part of the AI Startup Landscape and are looking forward to great collaborations and future projects within the AI startup community!

0